Medical Cannabis for Treatment of Insomnia in Adults:
A Systematic Review and Meta-Analysis 

References

Aiewtrakoon, C. (2024). Efficacy and safety of cannabidiol oil on chronic insomnia: The first randomized, double-blind, placebo-controlled, crossover, pilot study in thailand. Journal of the Medical Association of Thailand, 107(3), 160-170. https://doi.org/10.35755/jmedassocthai.2024.3.13952  

American Academy of Sleep Medicine. (2023). International classification of sleep disorders. American Academy of Sleep Medicine. http://www.aasmnet.org  

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders, 5th ed., text revision. [APA] https://doi.org/https://doi.org/10.1176/appi.books.9780890425787  

Axtell, R. S., Burkart, S., Venard, A., Bodurtha, P., Brunello, G., Bukowski, Z., & Lunn, W. R. (2024). Effects of chronic cannabidiol supplementation on sleep hygiene in young adults. Medicine & Science in Sports & Exercise, 56(10), 499-499.  

Bargnes, V., Hart, P., Gupta, S., & Mechtler, L. (2019). Safety and efficacy of medical cannabis in elderly patients: A retrospective review in a neurological outpatient setting. Neurology, 92(15, Suppl), Article P4.1-014. https://www.embase.com/search/results?subaction=viewrecord&id=L629494099&from=export  

Bonn-Miller, M. O., Feldner, M. T., Bynion, T. M., Eglit, G. M. L., Brunstetter, M., Kalaba, M., Zvorsky, I., Peters, E. N., & Hennesy, M. (2024). A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality. Experimental and Clinical Psychopharmacology, 32(3), 277-284. https://doi.org/10.1037/pha0000682  

Bugatti, M., Owen, J., Reese, R. J., Coleman, J., Richardson, Z., Rasmussen, W., & Newton, D. A. (2023). Access to care and cost as predictors of early psychotherapy dropout: Findings from a technology-enabled practice research group. Practice Innovations, 8(1), 62-74. https://doi.org/10.1037/pri0000200  

Cochrane Methods Bias Group. (2024, November 22). Robins-i v2 tool. https://sites.google.com/site/riskofbiastool/welcome/robins-i-v2?authuser=0 

DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials*. Controlled Clinical Trials, 7(3), 177-188. https://doi.org/10.1016/0197-2456(86)90046-2  

Dokkedal-Silva, V., Oliveira, M. G. M., Galduróz, J. C. F., Tufik, S., & Andersen, M. L. (2021). The effect of sleep medications on prospective and retrospective memory: A population-based study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 104, Article 110043. https://doi.org/10.1016/j.pnpbp.2020.110043  

Du, M., Liu, M., Wang, Y., Qin, C., & Liu, J. (2024). Global burden of sleep disturbances among older adults and the disparities by geographical regions and pandemic periods. SSM Population Health, 25, Article 101588. https://doi.org/10.1016/j.ssmph.2023.101588  

Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., Zhou, E. S., Kazmi, U., Heald, J. L., & Martin, J. L. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(2), 255-262. https://doi.org/10.5664/jcsm.8986  

Edinoff, A. N., Nix, C. A., Hollier, J., Sagrera, C. E., Delacroix, B. M., Abubakar, T., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2021). Benzodiazepines: Uses, dangers, and clinical considerations. Neurology International, 13(4), 594-607. https://doi.org/10.3390/neurolint13040059  

Gilman, J. M., Schuster, R. M., Potter, K. W., Schmitt, W., Wheeler, G., Pachas, G. N., Hickey, S., Cooke, M. E., Dechert, A., Plummer, R., Tervo-Clemmens, B., Schoenfeld, D. A., & Evins, A. E. (2022). Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms in adults: A randomized clinical trial. JAMA Network Open, 5(3), e222106. https://doi.org/10.1001/jamanetworkopen.2022.2106  

Hafner, M., Romaelli, R. J., Yerushalmi, E., & Troxel, W. M. (2023). The societal and economic burden of insomnia in adults: An international study. RAND Europe. https://www.rand.org/content/dam/rand/pubs/research_reports/RRA2100/RRA2166-1/RAND_RRA2166-1.pdf 

Hafner, M., Stepanek, M., Taylor, J., Troxel, W. M., & van Stolk, C. (2017). Why sleep matters-the economic costs of insufficient sleep: A cross-country comparative analysis  [Report]. RAND EUROPE. https://www.rand.org/pubs/research_reports/RR1791.html [download link]  

Hancox, R. J., Gray, A. R., Zhang, X., Poulton, R., Moffitt, T. E., Caspi, A., & Sears, M. R. (2022). Differential effects of cannabis and tobacco on lung function in mid-adult life. American Journal of Respiratory and Critical Care Medicine, 205(10), 1179-1185. https://doi.org/10.1164/rccm.202109-2058OC  

Healthy People 2030. (n.d.-a). Increase the proportion of  adults who get enough sleep— sh-03. U. S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. https://health.gov/healthypeople/objectives-and-data/browse-objectives/sleep/increase-proportion-adults-who-get-enough-sleep-sh-03 

Healthy People 2030. (n.d.-b). Sleep. U. S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Retrieved July 18 from https://health.gov/healthypeople/objectives-and-data/browse-objectives/sleep 

Hoyos, C., Marshall, N., Gordon, C., Yee, B., McGregor, I., & Grunstein, R. R. (2024). The cannabidiol use for relief of short-term insomnia (can-rest). A randomised placebocontrolled clinical trial. Sleep, 47, A169-A170. https://doi.org/10.1093/sleep/zsae067.0394  

Huedo-Medina, T. B., Sánchez-Meca, J., Marín-Martínez, F., & Botella, J. (2006). Assessing heterogeneity in meta-analysis: Q statistic or I² index? Psychological Methods, 11(2), 193-206. https://doi.org/10.1037/1082-989x.11.2.193  

Kalaba, M., & Ware, M. A. (2022). Cannabinoid profiles in medical cannabis users: Effects of age, gender, symptoms, and duration of use. Cannabis and Cannabinoid Research, 7(6), 840-851. https://doi.org/10.1089/can.2020.0120  

Kisiolek, J. N., Flores, V. A., Ramani, A., Butler, B., Haughian, J. M., & Stewart, L. K. (2023). Eight weeks of daily cannabidiol supplementation improves sleep quality and immune cell cytotoxicity. Nutrients, 15(19). https://doi.org/10.3390/nu15194173  

Kolobaric, A., Hewlings, S. J., Bryant, C., Colwell, C. S., C, R. D. A., Rosner, B., Chen, J., & Pauli, E. K. (2023). A randomized, double-blind, placebo-controlled decentralized trial to assess sleep, health outcomes, and overall well-being in healthy adults reporting disturbed sleep, taking a melatonin-free supplement. Nutrients, 15(17), Article 3788. https://doi.org/10.3390/nu15173788  

Kolobaric, A., Saleska, J., Hewlings, S. J., Bryant, C., Colwell, C. S., D’Adamo, C. R., Chen, J., & Pauli, E. K. (2024). A randomized, double-blind, placebo-controlled trial to assess the effectiveness and safety of melatonin and three formulations of floraworks proprietary trucbn™ for improving sleep. Pharmaceuticals (Basel, Switzerland), 17(8). https://doi.org/10.3390/ph17080977  

Kuhathasan, N., Minuzzi, L., MacKillop, J., & Frey, B. N. (2021). The use of cannabinoids for insomnia in daily life: Naturalistic study. Journal of Medical Internet Research, 23(10), e25730. https://doi.org/10.2196/25730  

Manber, R., Simpson, N., & Gumport, N. B. (2023). Perspectives on increasing the impact and reach of CBT-I. Sleep, 46(12), Article zsad168. https://doi.org/10.1093/sleep/zsad168  

McGowan, J., Sampson, M., Salzwedel, D. M., Cogo, E., Foerster, V., & Lefebvre, C. (2016). Press peer review of electronic search strategies: 2015 guideline statement. Journal of Clinical Epidemiology, 75, 40-46. https://doi.org/10.1016/j.jclinepi.2016.01.021  

McGuinness, L. A., & Higgins, J. P. T. (2021). Risk-of-bias visualization (robvis): An r package and shiny web app for visualizing risk-of-bias assessments. Res Synth Methods, 12(1), 55-61. https://doi.org/10.1002/jrsm.1411  

Morris, S. B. (2008). Estimating effect sizes from pretest-posttest-control group designs. Organizational Research Methods, 11(2), 364-386. https://doi.org/https://doi.org/10.1177/1094428106291059  

Narayan, A. J., Downey, L. A., Rose, S., Di Natale, L., & Hayley, A. C. (2024). Cannabidiol for moderate-severe insomnia: A randomized controlled pilot trial of 150 mg of nightly dosing. Journal of Clinical Sleep Medicine, 20(5), 753-763. https://doi.org/10.5664/jcsm.10998  

National Academies of Sciences, E., and Medicine,. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. National Academies Press.  

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S.,…Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, Article n71. https://doi.org/10.1136/bmj.n71  

Pankowska, M. M., Lu, H., Wheaton, A. G., Liu, Y., Lee, B., Greenlund, K. J., & Carlson, S. A. (2023). Prevalence and geographic patterns of self-reported short sleep duration among US adults, 2020. Preventing Chronic Disease, 20(June), Article E53. https://doi.org/10.5888/pcd20.220400  

Ramar, K., Malhotra, R. K., Carden, K. A., Martin, J. L., Abbasi-Feinberg, F., Aurora, R. N., Kapur, V. K., Olson, E. J., Rosen, C. L., Rowley, J. A., Shelgikar, A. V., & Trotti, L. M. (2021). Sleep is essential to health: An American Academy of Sleep Medicine position statement. Journal of Clinical Sleep Medicine, 17(10), 2115-2119. https://doi.org/10.5664/jcsm.9476  

Ried, K., Tamanna, T., Matthews, S., & Sali, A. (2023). Medicinal cannabis improves sleep in adults with insomnia: A randomised double-blind placebo-controlled crossover study. Journal of Sleep Research, 32(3), e13793. https://doi.org/10.1111/jsr.13793  

Saleska, J. L., Bryant, C., Kolobaric, A., D’Adamo, C. R., Colwell, C. S., Loewy, D., Chen, J., & Pauli, E. K. (2024). The safety and comparative effectiveness of non-psychoactive cannabinoid formulations for the improvement of sleep: A double-blinded, randomized controlled trial. Journal of the American Nutrition Association, 43(1), 1-11. https://doi.org/10.1080/27697061.2023.2203221  

Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13(02), 307-349. https://doi.org/10.5664/jcsm.6470  

Schünemann, H., Brożek, J., Guyatt, G., & Oxman, A. (2013, October). GRADE handbook for grading quality of evidence and strength of recommendations. GRADE Working Group. https://gdt.gradepro.org/app/handbook/handbook.htm  

Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & Group, P.-P. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-p) 2015: Elaboration and explanation. BMJ, 350, Article g7647. https://doi.org/10.1136/bmj.g7647  

Sletten, T. L., Weaver, M. D., Foster, R. G., Gozal, D., Klerman, E. B., Rajaratnam, S. M. W., Roenneberg, T., Takahashi, J. S., Turek, F. W., Vitiello, M. V., Young, M. W., & Czeisler, C. A. (2023). The importance of sleep regularity: A consensus statement of the National Sleep Foundation sleep timing and variability panel. Sleep Health, 9(6), 801-820. https://doi.org/10.1016/j.sleh.2023.07.016  

Sterne, J. A. C., Savovic, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H. Y., Corbett, M. S., Eldridge, S. M., Emberson, J. R., Hernan, M. A., Hopewell, S., Hrobjartsson, A., Junqueira, D. R., Juni, P., Kirkham, J. J., Lasserson, T., Li, T.,…Higgins, J. P. T. (2019). Rob 2: A revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898. https://doi.org/10.1136/bmj.l4898  

Stickley, A., Leinsalu, M., DeVylder, J. E., Inoue, Y., & Koyanagi, A. (2019). Sleep problems and depression among 237 023 community-dwelling adults in 46 low- and middle-income countries. Scientific Reports, 9(1), Article 12011. https://doi.org/10.1038/s41598-019-48334-7  

Stranges, S., Tigbe, W., Gómez-Olivé, F. X., Thorogood, M., & Kandala, N. B. (2012). Sleep problems: An emerging global epidemic? Findings from the INDEPTH WHO-SAGE study among more than 40,000 older adults from 8 countries across Africa and Asia. Sleep, 35(8), 1173-1181. https://doi.org/10.5665/sleep.2012  

Suraev, A., McGregor, I., Marshall, N., Kao, T., D’Rozario, A., Grunstein, R., & Hoyos, C. (2023). Acute effects of cannabinoids in insomnia disorder: A randomised, placebo-controlled trial using high-density eeg. Sleep, 46(Suppl 1), A164-A165.  

Suraev, A., Mills, L., Abelev, S. V., Arkell, T. R., Lintzeris, N., & McGregor, I. S. (2023). Medical cannabis use patterns for sleep disorders in australia: Results of the cross-sectional cams-20 survey. Nature and the Science of Sleep, 15, 245-255. https://doi.org/10.2147/NSS.S390583  

United States Centers for Disease Control and Prevention. (2024). Faststats: Sleep in adults. https://www.cdc.gov/sleep/data-research/facts-stats/adults-sleep-facts-and-stats.html 

Vaillancourt, R., Gallagher, S., Cameron, J. D., & Dhalla, R. (2022). Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 155(3), 175-180. https://doi.org/10.1177/17151635221089617  

Walsh, J. H., Maddison, K. J., Rankin, T., Murray, K., McArdle, N., Ree, M. J., Hillman, D. R., & Eastwood, P. R. (2021). Treating insomnia symptoms with medicinal cannabis: A randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo. Sleep, 44(11). https://doi.org/10.1093/sleep/zsab149  

Wang, M., Faust, M., Abbott, S., Patel, V., Chang, E., Clark, J. I., Stella, N., & Muchowski, P. J. (2025). Effects of a cannabidiol/terpene formulation on sleep in individuals with insomnia: A double-blind, placebo-controlled, randomized, crossover study. Journal of Clinical Sleep Medicine, 21(1), 69-80. https://doi.org/10.5664/jcsm.11324  

Wang, S., Rossheim, M. E., & Nandy, R. R. (2023). Trends in prevalence of short sleep duration and trouble sleeping among US adults, 2005-2018. Sleep, 46(1), Article zsac231. https://doi.org/10.1093/sleep/zsac231  

Watson, N. F., Badr, M. S., Belenky, G., Bliwise, D. L., Buxton, O. M., Buysse, D., Dinges, D. F., Gangwisch, J., Grandner, M. A., Kushida, C., Malhotra, R. K., Martin, J. L., Patel, S. R., Quan, S. F., & Tasali, E. (2015). Joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society on the recommended amount of sleep for a healthy adult: Methodology and discussion. Journal of Clinical Sleep Medicine, 11(8), 931-952. https://doi.org/10.5664/jcsm.4950